CLINIQUE
- Product NDC
- 49527-112
- 11-digit product format
- 495270112
- Labeler code
- 49527
- Product ID
- 49527-112_f0d94c0c-05fd-9f49-e053-2995a90ac784
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- OCTISALATE, AVOBENZONE, and OCTOCRYLENE
- Dosage form
- LOTION
- Route
- TOPICAL
- Labeler
- CLINIQUE LABORATORIES LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2011-11-01
- Marketing end
- 0000-00-00
- Substance
- AVOBENZONE; OCTISALATE; OCTOCRYLENE
- Active strength
- 30 mg/mL; mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 49527-112 | D | Discontinued by firm | 2026-11-16 | ||
| excluded package | package | 49527-112 | 49527-112-01 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49527-112-01 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49527-112-01 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49527-112-01 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49527-112-01 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49527-112-01 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49527-112-01 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49527-112-01 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49527-112-01 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49527-112-01 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 49527-112-01 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 49527-112-01 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 49527-112-01 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 49527-112-01 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2022-08-05 | CLINIQUE EVEN BETTER SKIN TONE CORRECTING LOTION BROAD SPECTRUM SPF 20 |
| 2022-07-29 | CLINIQUE EVEN BETTER SKIN TONE CORRECTING LOTION BROAD SPECTRUM SPF 20 |
| 2020-02-05 | CLINIQUE EVEN BETTER SKIN TONE CORRECTING LOTION BROAD SPECTRUM SPF 20 |
| 2020-01-31 | CLINIQUE EVEN BETTER SKIN TONE CORRECTING LOTION BROAD SPECTRUM SPF 20 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Banana Boat | AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE OXYBENZONE | Edgewell Personal Care Brands, LLC | 39a5a3be-f9a7-4fa1-e054-00144ff88e88 | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | AVOBENZONE HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fda2f46-4322-1284-e054-00144ff8d46c | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | AVOBENZONE HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fd8448c-5b3a-1a76-e054-00144ff88e88 | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fd69dcf-95e3-73bb-e054-00144ff8d46c | 2026-10-27 | Warnings | M020 |
| ANTI-AGING COMPLEX BROAD SPECTRUM SPF 30 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Merle Norman Cosmetics, Inc. | d10272ea-aedd-5759-e053-2a95a90a3ab3 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb338c7-e99c-887d-e063-6394a90a977c | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49527-112-01 | 49527011201 | 1 TUBE in 1 CARTON (49527-112-01) > 50 mL in 1 TUBE | 1 tube | 2011-11-01 | 0000-00-00 | No | No | Current |